Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Humbert, Marc ; Rådegran, Göran LU and Vonk Noordegraaf, Anton (2022) In European Heart Journal 43(38). p.3618-3731
Please use this url to cite or link to this publication:
author
; and
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Balloon pulmonary angioplasty, Chronic thrombo-embolic pulmonary hypertension, Congenital heart disease, Connective tissue disease, Endothelin receptor antagonists, Guidelines, Left heart disease, Lung disease, Lung transplantation, Phosphodiesterase type 5 inhibitors, Prostacyclin analogues, Prostacyclin receptor agonists, Pulmonary arterial hypertension, Pulmonary endarterectomy, Pulmonary hypertension, Soluble guanylate cyclase stimulators, Endothelin Receptor Antagonists, Humans, Hypertension, Pulmonary, ambrisentan, amlodipine, antiretrovirus agent, beraprost, beta adrenergic receptor blocking agent, bosentan, bosutinib, cyclophosphamide, dasatinib, diltiazem, dipeptidyl carboxypeptidase inhibitor, diuretic agent, endothelin receptor antagonist, enkephalinase inhibitor, felodipine, guanylate cyclase activator, iloprost, interferon, ivabradine, macitentan, methamphetamine, mitomycin, nifedipine, phosphodiesterase V inhibitor, Pneumococcus vaccine, ponatinib, prostacyclin, prostacyclin derivative, riociguat, SARS-CoV-2 vaccine, selexipag, sildenafil, sodium glucose cotransporter 2 inhibitor, tadalafil, treprostinil, abdominal radiography, altitude, angioplasty, anticoagulant therapy, aortic stenosis, aortopulmonary shunt, arterial gas, assisted circulation, biochemical analysis, birth control, blood analysis, BMPR2 gene, cardiopulmonary exercise test, cardiovascular magnetic resonance, chronic kidney failure, chronic obstructive lung disease, chronic thromboembolic pulmonary hypertension, clinical decision making, comorbidity, congenital heart disease, connective tissue disease, contraceptive behavior, coronavirus disease 2019, denervation, digital subtraction angiography, disease association, disease classification, disease control, disease course, disease severity, drug approval, drug design, drug potentiation, drug safety, dynamic contrast enhanced computed tomography, early diagnosis, echocardiography, echography, electrocardiogram, Europe, evidence based practice, exercise, fluid challenge test, follow up, gene, genetic counseling, genetic screening, GRADE approach, health care facility, health care management, health care personnel, heart arrhythmia, heart catheterization, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, heart left ventricle hypertrophy, heart lung transplantation, heart right ventricle failure, hematologic disease, hemoptysis, human, Human immunodeficiency virus infection, hypoxia, immunology, intensive care unit, interstitial lung disease, iron deficiency anemia, liver transplantation, lung artery pressure, lung embolism, lung emphysema, lung function test, lung hemodynamics, lung transplantation, mediastinitis, metabolic disorder, microangiopathy, mitral valve disease, mortality risk, noninvasive ventilation, oxygen therapy, pathophysiology, patient compliance, patient empowerment, patient-reported outcome, phase 3 clinical trial (topic), physical activity, pneumococcal infection, portal hypertension, practice guideline, pregnancy, prognosis, psychosocial care, pulmonary artery denervation, pulmonary artery occlusion, pulmonary endarterectomy, pulmonary hypertension, pulmonary tumour thrombotic microangiopathy, rehabilitation care, Review, risk assessment, risk factor, schistosomiasis, surgical technique, systemic disease, systemic sclerosis, telemonitoring, terminal care, thorax radiography, thrombotic microangiopathy, travel, tricuspid valve regurgitation, vaccination, vasoreactivity test, ventilation-perfusion scan
in
European Heart Journal
volume
43
issue
38
pages
114 pages
publisher
Oxford University Press
external identifiers
  • scopus:85139739040
ISSN
1522-9645
DOI
10.1093/eurheartj/ehac237
language
English
LU publication?
yes
id
df9f0e5a-4692-4133-8f58-581cc5ab4490
date added to LUP
2024-03-27 10:40:02
date last changed
2024-03-27 10:40:41
@article{df9f0e5a-4692-4133-8f58-581cc5ab4490,
  author       = {{Humbert, Marc and Rådegran, Göran and Vonk Noordegraaf, Anton}},
  issn         = {{1522-9645}},
  keywords     = {{Balloon pulmonary angioplasty; Chronic thrombo-embolic pulmonary hypertension; Congenital heart disease; Connective tissue disease; Endothelin receptor antagonists; Guidelines; Left heart disease; Lung disease; Lung transplantation; Phosphodiesterase type 5 inhibitors; Prostacyclin analogues; Prostacyclin receptor agonists; Pulmonary arterial hypertension; Pulmonary endarterectomy; Pulmonary hypertension; Soluble guanylate cyclase stimulators; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; ambrisentan; amlodipine; antiretrovirus agent; beraprost; beta adrenergic receptor blocking agent; bosentan; bosutinib; cyclophosphamide; dasatinib; diltiazem; dipeptidyl carboxypeptidase inhibitor; diuretic agent; endothelin receptor antagonist; enkephalinase inhibitor; felodipine; guanylate cyclase activator; iloprost; interferon; ivabradine; macitentan; methamphetamine; mitomycin; nifedipine; phosphodiesterase V inhibitor; Pneumococcus vaccine; ponatinib; prostacyclin; prostacyclin derivative; riociguat; SARS-CoV-2 vaccine; selexipag; sildenafil; sodium glucose cotransporter 2 inhibitor; tadalafil; treprostinil; abdominal radiography; altitude; angioplasty; anticoagulant therapy; aortic stenosis; aortopulmonary shunt; arterial gas; assisted circulation; biochemical analysis; birth control; blood analysis; BMPR2 gene; cardiopulmonary exercise test; cardiovascular magnetic resonance; chronic kidney failure; chronic obstructive lung disease; chronic thromboembolic pulmonary hypertension; clinical decision making; comorbidity; congenital heart disease; connective tissue disease; contraceptive behavior; coronavirus disease 2019; denervation; digital subtraction angiography; disease association; disease classification; disease control; disease course; disease severity; drug approval; drug design; drug potentiation; drug safety; dynamic contrast enhanced computed tomography; early diagnosis; echocardiography; echography; electrocardiogram; Europe; evidence based practice; exercise; fluid challenge test; follow up; gene; genetic counseling; genetic screening; GRADE approach; health care facility; health care management; health care personnel; heart arrhythmia; heart catheterization; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; heart left ventricle hypertrophy; heart lung transplantation; heart right ventricle failure; hematologic disease; hemoptysis; human; Human immunodeficiency virus infection; hypoxia; immunology; intensive care unit; interstitial lung disease; iron deficiency anemia; liver transplantation; lung artery pressure; lung embolism; lung emphysema; lung function test; lung hemodynamics; lung transplantation; mediastinitis; metabolic disorder; microangiopathy; mitral valve disease; mortality risk; noninvasive ventilation; oxygen therapy; pathophysiology; patient compliance; patient empowerment; patient-reported outcome; phase 3 clinical trial (topic); physical activity; pneumococcal infection; portal hypertension; practice guideline; pregnancy; prognosis; psychosocial care; pulmonary artery denervation; pulmonary artery occlusion; pulmonary endarterectomy; pulmonary hypertension; pulmonary tumour thrombotic microangiopathy; rehabilitation care; Review; risk assessment; risk factor; schistosomiasis; surgical technique; systemic disease; systemic sclerosis; telemonitoring; terminal care; thorax radiography; thrombotic microangiopathy; travel; tricuspid valve regurgitation; vaccination; vasoreactivity test; ventilation-perfusion scan}},
  language     = {{eng}},
  number       = {{38}},
  pages        = {{3618--3731}},
  publisher    = {{Oxford University Press}},
  series       = {{European Heart Journal}},
  title        = {{2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension}},
  url          = {{http://dx.doi.org/10.1093/eurheartj/ehac237}},
  doi          = {{10.1093/eurheartj/ehac237}},
  volume       = {{43}},
  year         = {{2022}},
}